Knockout of beta(1)- and beta(2)-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis.
about
Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytesLamina-associated polypeptide 2alpha loss impairs heart function and stress response in mice.Functional β-adrenoceptors are important for early muscle regeneration in mice through effects on myoblast proliferation and differentiationCardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy.Myocardial oxidative stress contributes to transgenic β₂-adrenoceptor activation-induced cardiomyopathy and heart failure.Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.Cardiac pressure overload hypertrophy is differentially regulated by β-adrenergic receptor subtypes.A metabolite of Danshen formulae attenuates cardiac fibrosis induced by isoprenaline, via a NOX2/ROS/p38 pathway.Proliferation in cardiac fibroblasts induced by β1-adrenoceptor autoantibody and the underlying mechanisms.Chronic activation of the low affinity site of β1-adrenoceptors stimulates haemodynamics but exacerbates pressure-overload cardiac remodelling.Beta1-adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction.Prognostic value of serum PIIINP, MMP1 and TIMP1 levels in hypertensive patients: a community-based prospective cohort study.Echocardiographic assessment of β-adrenoceptor stimulation-induced heart failure with reduced heart rate in mice.Gender-related differences in β-adrenergic receptor-mediated cardiac remodeling.Decrease in heart adrenoceptor gene expression and receptor number as compensatory tool for preserved heart function and biological rhythm in M(2) KO animals.
P2860
Q27967859-F7E4175B-C2C0-4C5F-A23F-5A22A230447FQ33639577-B794E3D6-CA73-4B5E-BDD0-95990FDC5E35Q33855954-D82CD4DC-B99E-42DD-AF11-E501F157C3BAQ33869828-AF0AA4C3-48CC-4CBE-9C2D-26510B88677FQ34636226-5381C5BA-00B3-4BD3-80C2-152C4025E5B0Q34892203-0262D0E4-BC73-494B-A2DE-3011D9340BC4Q35395744-80504C3A-593B-44E4-A58F-0FAB321A87F4Q36342127-F7D1E11A-83E0-4911-9B0D-A8BC6F0AC520Q37220612-C9270172-F19E-4636-8514-42453BC6D232Q37327391-B0A469DC-3902-4AF8-946A-924B444599BEQ37406363-84A91B29-A72E-425A-A633-7754482C62A4Q47392248-D5AEA3EB-C402-4A8C-BC03-5BCF2E8D43B2Q47963339-4229CBFE-325D-4B36-8C75-1A9F56480646Q47983169-4F9A298E-71B2-4D07-8346-EE6A75DF12E2Q52631071-CE5B6E26-34E2-42C9-BB8C-543236132ADB
P2860
Knockout of beta(1)- and beta(2)-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Knockout of beta(1)- and beta( ...... diac hypertrophy and fibrosis.
@ast
Knockout of beta(1)- and beta( ...... diac hypertrophy and fibrosis.
@en
type
label
Knockout of beta(1)- and beta( ...... diac hypertrophy and fibrosis.
@ast
Knockout of beta(1)- and beta( ...... diac hypertrophy and fibrosis.
@en
prefLabel
Knockout of beta(1)- and beta( ...... diac hypertrophy and fibrosis.
@ast
Knockout of beta(1)- and beta( ...... diac hypertrophy and fibrosis.
@en
P2093
P2860
P356
P1476
Knockout of beta(1)- and beta( ...... diac hypertrophy and fibrosis.
@en
P2093
H Kiriazis
P2860
P304
P356
10.1038/SJ.BJP.0707622
P407
P577
2008-01-14T00:00:00Z